Pancreatic Cancer | sciencenewsnet.in

Atlantic Health System Cancer Care Enrolling Patients in Innovative Pancreatic Cancer Clinical Trials

October 30, 2019 sarah Jonas 0 Comments Atlantic Health System Cancer Care, Clinical Trials, Immunotherapy, Morristown Medical Center, Overlook Medical Center, Pancreatic Cancer, pembrolizumab

November is national Pancreatic Cancer Awareness month. This year alone, more than 56,000 Americans will be diagnosed with pancreatic cancer. Pancreatic tumors are particularly aggressive and hard to treat “due to a mutational profile that makes it resistant to therapies that work better for other tumor types,” explains Angela Alistar, MD, medical director of GI oncology at Morristown Medical Center. Dr. Alistar, an internationally known expert on pancreatic cancer, is now enrolling patients in five clinical trials aimed at pancreatic cancer.

Research Results

Vaccine to Block Digestive Hormone May Slow Growth of Pancreatic Cancer

October 10, 2019 sarah Jonas 0 Comments Cancer Treatment, Cancerous Tumors, Pancreatic Cancer, Physiology, Vaccine

New research suggests a vaccine that blocks a digestive hormone may slow the spread of pancreatic cancer, potentially increasing survival rates. The study, published ahead of print in the American Journal of Physiology—Gastrointestinal and Liver Physiology, was chosen as an APSselect article for October.

Research Results

MD Anderson study confirms protein as potential cause of most common type of pancreatic cancer

September 4, 2019 sarah Jonas 0 Comments Cancer, Cancer Research, Md Anderson, MD Anderson Cancer Center, Pancreas Cancer, Pancreatic Cancer

An oncogene, UPS21, has been confirmed as a frequently amplified gene in pancreatic ductal adenocarcinoma, the most common and often lethal form of pancreatic cancer. The discovery could lead to new treatment options.

Research Results

Nerves Could be Key to Pancreatic Cancer Spread

August 29, 2019 sarah Jonas 0 Comments Johns Hopkins Kimmel Cancer Center, Pancreatic Cancer

A couple of molecules that nerve cells use to grow during development could help explain why the most common pancreatic cancers are so difficult to contain and for patients to survive